Company Overview and News

 
Pritish Nandy Communications Limited - Updates

2018-09-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

 
Pritish Nandy Communications Limited - Shareholders meeting

2018-09-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

 
Pritish Nandy Communications Limited - Book Closure

2018-09-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

 
Pritish Nandy Communications Limited - Updates

2018-09-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

 
Network18, Mahindra CIE, PC Jeweller, Vakrangee top gainers among #39;A#39; group stocks, up 10-13%

2018-09-03 moneycontrol
The Indian market has turned negative intraday despite opening the week on a positive note with the Nifty down 37 points and trading around 11,643-mark while the Sensex shed 111 points trading around 38,533 mark.
FOSECOIND CELESTIAL 532638 ALBERTDA 500150 532178 532387 532871 524075 ENGINERSIN PNC JAGSNPHARM 534809 PCJEWELLER 507789 SHOPERSTOP

 
Pritish Nandy Communications Limited - Shareholders meeting

2018-09-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

 
Check out insider trades for August 9; Axis Bank, ICICI Bank, Jubilant FoodWorks in focus

2018-08-13 moneycontrol
K.M.Sugar Mills Ltd.: Umadevi Jhunjhunwala bought 1,77,831 shares through market purchase from August 7 to August 9, 2018
SRIPIPES AXB 500228 IBN HDFC 533155 JUBLFOOD JSWSTEEL 532215 AXBKY AXBA 532387 ICICIBANK AXISBANK 532174 513605 JBLWY PNC 500010 HDFC

 
Pritish Nandy Communications Limited - Updates

2018-07-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

 
Pritish Nandy Communications Limited - Financial Result Updates

2018-07-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

 
Pritish Nandy Communications Limited - Outcome of Board Meeting

2018-07-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

 
Focus on Bandhan Bank, UltraTech, RCom results

2018-07-17 thehindubusinessline
Seventeen companies will declare their first quarter results of the current financial year on Wednesday. Among these are Artson Engineering, Bandhan Bank, Foseco India (second quarter and half-year results), GHCL, HT Media, JK Tyres & Industries, JM Financial, Mahindra CIE Automotive, Mastek, MindTree, NIIT Technologies, Pritish Nandy Communications, Responsive Industries, Reliance Communications, Sasken Technologies, UltraTech Cement and Warren Tea.
523405 NIITTECH FOSECOIND RESPONIND 505509 ARTSONEN HTMEDIA 532538 UCLQF 532712 532756 WARRENTEA ULTRACEMCO 500150 532387 532662 532541 RCOM UCLQY PNC 508494 MAHINDCIE 522134 JMFINANCIL

 
Pritish Nandy Communications Limited - Clarification - Financial Results

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

 
Pritish Nandy Communications Limited - Reply to Clarification- Financial results

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

 
Pritish Nandy Communications Limited - Clarification - Financial Results

2018-05-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532387 PNC

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to NSE:PNC / PRITISH NANDY COMMUNICATIONS LTD. on message board site Silicon Investor.

Spectranetics (SPNC): Any info? Spectranetics (SPNC): Any info? Spectranetics (SPNC): Any info? PNC BANK PNC BANK PNC BANK
PINNACLE MICRO (PNCL) - A QUALITY PICK FOR u002798 PINNACLE MICRO (PNCL) - A QUALITY PICK FOR u002798 PINNACLE MICRO (PNCL) - A QUALITY PICK FOR u002798 PNCL -- Buy/Sell/Hold in the New Year PNCL -- Buy/Sell/Hold in the New Year PNCL -- Buy/Sell/Hold in the New Year